MPAM
CRNX icon

Monarch Partners Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Monarch Partners Asset Management’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$2.36M Sell
2022
Q3 		$2.57M Buy